Walleye Capital LLC Atai Life Sciences N.V. Transaction History
Walleye Capital LLC
- $54.3 Billion
- Q2 2024
A detailed history of Walleye Capital LLC transactions in Atai Life Sciences N.V. stock. As of the latest transaction made, Walleye Capital LLC holds 2,762,760 shares of ATAI stock, worth $3.59 Million. This represents 0.01% of its overall portfolio holdings.
Number of Shares
2,762,760
Previous 102,368
2598.85%
Holding current value
$3.59 Million
Previous $201,000
1727.86%
% of portfolio
0.01%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding ATAI
# of Institutions
99Shares Held
12.7MCall Options Held
9.2KPut Options Held
118K-
Morgan Stanley New York, NY2.72MShares$3.53 Million0.0% of portfolio
-
Black Rock Inc. New York, NY1.31MShares$1.7 Million0.0% of portfolio
-
Brown University719KShares$934,0500.39% of portfolio
-
Two Sigma Investments, LP New York, NY717KShares$932,2700.0% of portfolio
-
Round Table Services, LLC704KShares$915,2000.46% of portfolio
About ATAI Life Sciences N.V.
- Ticker ATAI
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 165,875,008
- Market Cap $216M
- Description
- Atai Life Sciences N.V., through its subsidiary, ATAI Life Sciences AG, operates as a clinical-stage biopharmaceutical company. It engages in developing various therapeutic candidates that focuses on various mental health disorders. The company's therapeutic candidates include PCN-101, a subcutaneous formulation of R-ketamine for the treatment o...